NCT02251236: A trial that was reported late by University of California, San Diego
This trial has reported, although it was 628 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02251236 |
|---|---|
| Title | Elvitegravir (EVG) Cerebrospinal Fluid (CSF) Pharmacokinetics in HIV-Infected Individuals |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Jan. 31, 2016 |
| Completion date | Jan. 18, 2017 |
| Required reporting date | Jan. 18, 2018, midnight |
| Actual reporting date | Oct. 8, 2019 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | 628 |